Abbott Laboratories (ABT)

Total Liabilities

$57.45B

Quarterly · Period ending: · USD

ABT logo

ABT Total Liabilities

Latest reported$57.45B
ABT Quarterly Total Liabilities ($1.60B → $57.45B)
High-resolution chart · PNG

ABT total liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Total Liabilities — Quarterly (USD)
Period endingTotal Liabilities (USD)
57,453,000,000
57,728,000,000
33,942,000,000
32,917,000,000
33,170,000,000
32,384,000,000
33,513,000,000
34,328,000,000
33,457,000,000
33,424,000,000
34,387,000,000
34,396,000,000
35,950,000,000
36,562,000,000
37,533,000,000
36,917,000,000
37,486,000,000
38,378,000,000
39,172,000,000
39,157,000,000
39,240,000,000
38,997,000,000
39,545,000,000
37,448,000,000
37,978,000,000
36,350,000,000
36,586,000,000
36,520,000,000
36,533,000,000
36,481,000,000
36,451,000,000
40,739,000,000
37,641,000,000
39,307,000,000
45,152,000,000
40,030,000,000
39,363,000,000
39,340,000,000
31,949,000,000
18,601,000,000
19,036,000,000
18,795,000,000
19,921,000,000
20,506,000,000
20,999,000,000
21,107,000,000
19,636,000,000
19,521,000,000
17,771,000,000
18,173,000,000
17,686,000,000
20,344,546,000
20,475,700,000
20,003,338,000
40,421,712,000
36,153,397,000
37,287,305,000
36,872,367,000
35,750,748,000
34,939,204,000
35,534,538,000
36,931,031,000
36,985,802,000
35,890,896,000
33,386,768,000
32,346,282,000
29,517,894,000
28,472,070,000
27,709,949,000
27,454,457,000
24,939,653,000
22,407,177,000
25,114,917,000
23,198,028,000
21,935,384,000
22,013,749,000
21,819,069,000
21,966,976,000
22,123,986,000
17,666,471,000
18,875,761,000
14,089,355,000
14,725,932,000
14,567,928,000
13,435,302,000
14,679,666,000
14,441,711,000
14,608,882,000
14,860,315,000
14,541,291,000
13,643,084,000
14,289,982,000
13,998,018,000
13,511,173,000
13,594,549,000
13,113,182,000
13,164,305,000
13,319,973,000
14,236,991,000
14,048,334,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.